Morey Blinder is a Hematology physician affiliated with Washington University in St. Louis. OpenAlex indexes 78 publications with 3,973 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4500 Forest Park Ave
Div Im Hematology, 5th Fl
Saint Louis, MO 631082114
Telephone
314-362-7216Registry record last updated 15 Apr 2025.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20256 payments
- RECORDATI_RARE_DISEASES_INC.Program year20255 payments
- Beckman Coulter, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
69.5%Opioid Agonist60.3%Oxycodone Hcl29%Morphine Sulfate19%Methadone Hcl16%Hydromorphone Hcl16%Morphine Sulfate Er15%Oxycodone-Acetaminophen2%Oxycontin2%Tramadol Hcl1%Part D<11 patientsNonsteroidal Anti-inflammatory Drug3.8%Ibuprofen84%Meloxicam16%Part D<11 patients+ 6 more classes in this area
Blood & clotting
10.5%Factor Xa inhibitor6.9%Eliquis64%Xarelto36%Part D≥32 patientsVitamin K antagonist1.8%Warfarin Sodium100%Part D≥13 patients+ 3 more classes in this area
Cancer & immunology
6.8%Antimetabolite3.6%Hydroxyurea100%Part D≥42 patientsKinase inhibitor1.6%Imbruvica82%Brukinsa18%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis
Journal of Vascular Surgery Venous and Lymphatic Disorders
2019 - Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets
Current Medical Research and Opinion
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Ley, MD
Washington University in St. Louis
David Gutmann, MD
Washington University in St. Louis
Randall Bateman, MD
Washington University in St. Louis
Victoria Fraser, MD
Washington University in St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”